Ceribell (CBLL) Cash from Investing Activities (2023 - 2026)
Ceribell (CBLL) reported Cash from Investing Activities of $22.4 million for Q1 2026, up 175.79% on a YoY basis from $8.1 million in Q1 2025, and down 14.05% quarter-over-quarter from $26.1 million in Q4 2025.
Ceribell (CBLL) Cash from Investing Activities (2023 - 2026) Analysis & Trends
Ceribell has reported Cash from Investing Activities for 4 years, with the latest figure at $22.4 million in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities rose 175.79% year-over-year to $22.4 million; the trailing twelve-month figure through Mar 2026 stood at -$66.1 million (down 112.67% YoY), and the FY2025 full-year result was -$118.1 million, down 7292.8% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at $22.4 million, down from $26.1 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $26.1 million in Q4 2025, with the low at -$107.7 million in Q2 2025.
- Historically, Cash from Investing Activities has averaged -$9.8 million across 4 years, with a median of -$588000.0 in 2023.
- The largest YoY upside for Cash from Investing Activities was 5395.74% in 2025 against a maximum downside of 22331.06% in 2025.
- Ceribell's Cash from Investing Activities stood at -$683000.0 in 2023, then rose by 27.82% to -$493000.0 in 2024, then jumped by 5395.74% to $26.1 million in 2025, then retreated by 14.05% to $22.4 million in 2026.
- The last three Cash from Investing Activities figures came in at $22.4 million (Q1 2026), $26.1 million (Q4 2025), and -$6.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -92.80 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -2.50 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -298.50 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Ceribell | 695.83 Mn | 554.65 Mn | 23.12 Mn | 22.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.44 Mn |
| Mar 31, 2026 | 22.44 Mn |
| Dec 31, 2025 | 26.11 Mn |
| Dec 31, 2025 | 26.11 Mn |
| Sep 30, 2025 | -6.94 Mn |
| Sep 30, 2025 | -6.94 Mn |
| Jun 30, 2025 | -107.69 Mn |
| Jun 30, 2025 | -107.69 Mn |
| Mar 31, 2025 | -29.61 Mn |
| Mar 31, 2025 | -29.61 Mn |
| Dec 31, 2024 | -493,000.00 |
| Dec 31, 2024 | -493,000.00 |
| Sep 30, 2024 | 183,000.00 |
| Sep 30, 2024 | 183,000.00 |
| Jun 30, 2024 | -1.16 Mn |
| Jun 30, 2024 | -1.16 Mn |
| Mar 31, 2024 | -132,000.00 |
| Mar 31, 2024 | -132,000.00 |
| Dec 31, 2023 | -683,000.00 |
| Dec 31, 2023 | -683,000.00 |